Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
10 mars 2016 07h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...
Positive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
04 févr. 2016 15h15 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk...
Sera Prognostics Announces Clinical Study Data Selected for Presentation at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
07 janv. 2016 17h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that findings from the 5,501 patient Proteomic Assessment of Preterm Risk...
Sera Prognostics to Present at 34th Annual J.P. Morgan Healthcare Conference
21 déc. 2015 12h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, todayannounced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at 27th Annual Piper Jaffray Healthcare Conference
24 nov. 2015 12h24 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics Announces Early Limited Commercial Access of Its PreTRM™ Test
19 oct. 2015 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Oct. 19, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced a program for early limited commercial access to PreTRM™, a proteomic...
Sera Prognostics Appoints Investor Arnold L. Oronsky, Ph.D., to Board of Directors
24 févr. 2015 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that Arnold L. Oronsky, Ph.D., General Partner at InterWest Partners, LLC, was...
Sera Prognostics Increases Series B Financing to $25M With New Investor
04 févr. 2015 07h30 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 4, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that the Bill & Melinda Gates Foundation has agreed to join the Company's...
Sera Prognostics Closes $20 Million in Series B Financing
07 janv. 2015 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that it has closed $20 Million in Series B financing. Leading the Series B...
Sera Prognostics to Present at 33rd Annual J.P. Morgan Healthcare Conference
23 déc. 2014 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 23, 2014 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...